View Message in Browser

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

[link removed]

**The Latest Research, Commentary, and News from Health Affairs**

**Friday, March 13, 2020**

[link removed]

IN THE JOURNAL

AFFORDABLE CARE ACT

A Ten-Year Engagement: The Media And The ACA

By Julie Rovner

Julie Rovner discusses the challenges of covering the complex policies
and politics of the Affordable Care Act.
Read More >>

Read the March 2020 Table of Contents
.

Subscribe to Health Affairs for full journal access.

TODAY ON THE BLOG

AFFORDABLE CARE ACT

The following Health Affairs Blog posts are part of a short series, "The
ACA at 10: Health Care Revolution
," published with support
from the Solomon Center for Health Law and Policy at Yale Law School
and the Healthcare Transformation
Institute at the University of Pennsylvania's Perelman School of
Medicine, Department of Medical Ethics & Health Policy
.

The Affordable Care Act Made Health Care (Slightly) More Affordable

By Carrie Colla and Jonathan Skinner

In this post, we draw heavily on our recent contribution to a
forthcoming volume, "The Trillion Dollar Experiment," to estimate the
health care cost savings from the Affordable Care Act (ACA) over the
past decade, and then examine the lessons of the ACA to better
understand effective approaches for slowing the growth of health care
spending.Read More >>

Evaluating The ACA's Delivery System Reforms

By Ezekiel J. Emanuel, Amol S. Navathe, and Cathy Zhang

The Affordable Care Act included a number of types of delivery system
reforms (DSRs), such as changing payments to health care providers and
requiring greater reporting of quality and cost performance to the
public. Most DSRs targeted uncoordinated or inefficient care under the
traditional fee-for-service system. None of the programs has been a
clear home run, but many have made major steps in the right direction.
Read More >>

PHARMACEUTICALS AND MEDICAL TECHNOLOGY

Quality: The Often Overlooked Critical Element For Assuring Access To
Safe And Effective Drugs

By Janet Woodcock and Michael Kopcha

Part of our preparation includes addressing key technical and regulatory
issues ahead of time so as not to hinder promising technologies; we want
to make sure the technologies are not only adopted but that they deliver
on the promise of a higher level of manufacturing quality in the
pharmaceutical industry.
Read More >>

CONSIDERING HEALTH SPENDING

Prices Are Not "Reimbursements"

By Shivani A. Shah and Michael E. Chernew

We should set prices (and methods of payment) to balance access and
quality goals with budgetary concerns. Read More >>

A CLOSER LOOK-Drug Prices

The majority of Americans believe that lowering drug prices should be
the top health care priority for the federal government. Yet drug costs
as a proportion of the country's medical expenditures have increased
substantially in recent years. This Health Affairs article by Ezekiel J.
Emanuel asks, "When Is The Price Of A Drug Unjust?
"

[link removed]

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health Affairs
Today , and Health Affairs
Sunday Update .  

Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here
.                 
                                               
                        I